Blueberry and Cancer
In a 2005 study extracts were made of blueberry phenols, which
were freeze dried and further separated into phenolic acids, tannins, flavanols
and anthocyanins. The dried extracts were then added to cell cultures containing
two colon cancer cell lines – HT 29 and Caco-2. In concentrations normally found
in rat plasma after eating blueberries, anthocyanin fractions increased DNA
fragmentation – a indication that apostosis had been triggered – by between 2
and 7 times. Flavanol and tannin extracts cut cell proliferation time in half at
concentrations of 70-100 and 50-100 microg/mL. The phenolic fraction reduced
proliferation by a half at a concentration of 1000 microg/mL (Yi W, Fischer J,
Krewer G, Akoh CC. Phenolic compounds from blueberries can inhibit colon cancer
cell proliferation and induce apoptosis. J Agric Food Chem. 2005 Sep
7;53(18):7320-9).
Blueberries contain another antioxidant compound called
ellagic acid, which blocks metabolic pathways that can lead to cancer. A
study involving 1,271 subjects, showed that those who ate the most strawberries
(another food high in ellagic acid) were three times less likely to develop
cancer than those who ate few or no strawberries (Hannum SM. Potential impact of
strawberries on human health: a review of the science. Crit Rev Food Sci
Nutr. 44, 1:1-17, 2004).
Clinical Abstracts
Phenolic compounds from blueberries can inhibit colon cancer
cell proliferation and induce apoptosis.
J Agric Food Chem. 2005 Sep 7;53(18):7320-9
Department of Food Science and Technology, The University of
Georgia, Athens, Georgia 30602-7610, USA.
Research has shown that diets rich in phenolic compounds may be
associated with lower risks of several chronic diseases including cancer. This
study systematically evaluated the bioactivities of phenolic compounds in
rabbiteye blueberries and assessed their potential antiproliferation and
apoptosis induction effects using two colon cancer cell lines, HT-29 and Caco-2.
Polyphenols in three blueberry cultivars, Briteblue, Tifblue, and Powderblue,
were extracted and freeze-dried. The extracts were further separated into
phenolic acids, tannins, flavonols, and anthocyanins using an HLB cartridge and
LH20 column. Some individual phenolic acids and flavonoids were identified by
HPLC with >90% purity in anthocyanin fractions. The dried extracts and
fractions were added to the cell culture medium to test for antiproliferation
activities and induction of apoptosis. Flavonol and tannin fractions resulted in
50% inhibition of cell proliferation at concentrations of 70-100 and 50-100
microg/mL in HT-29 and Caco-2 cells, respectively. The phenolic acid fraction
showed relatively lower bioactivities with 50% inhibition at approximately 1000
microg/mL. The greatest antiproliferation effect among all four fractions was
from the anthocyanin fractions. Both HT-29 and Caco-2 cell growth was
significantly inhibited by >50% by the anthocyanin fractions at
concentrations of 15-50 microg/mL. Anthocyanin fractions also resulted in 2-7
times increases in DNA fragmentation, indicating the induction of apoptosis. The
effective dosage levels are close to the reported range of anthocyanin
concentrations in rat plasma. These findings suggest that blueberry intake may
reduce colon cancer risk.
PMID: 16131149 [PubMed - indexed for MEDLINE]
Blackberry, black raspberry, blueberry, cranberry, red
raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of
human cancer cells in vitro.
J Agric Food Chem. 2006 Dec 13;54(25):9329-39
Center for Human Nutrition, David Geffen School of Medicine,
University of California, Los Angeles, CA 90095, USA.
nseeram@mednet.ucla.edu
Berry fruits are widely consumed in our diet and have attracted
much attention due to their potential human health benefits. Berries contain a
diverse range of phytochemicals with biological properties such as antioxidant,
anticancer, anti-neurodegerative, and anti-inflammatory activities. In the
current study, extracts of six popularly consumed berries--blackberry, black
raspberry, blueberry, cranberry, red raspberry and strawberry--were evaluated
for their phenolic constituents using high performance liquid chromatography
with ultraviolet (HPLC-UV) and electrospray ionization mass spectrometry
(LC-ESI-MS) detection. The major classes of berry phenolics were anthocyanins,
flavonols, flavanols, ellagitannins, gallotannins, proanthocyanidins, and
phenolic acids. The berry extracts were evaluated for their ability to inhibit
the growth of human oral (KB, CAL-27), breast (MCF-7), colon (HT-29, HCT116),
and prostate (LNCaP) tumor cell lines at concentrations ranging from 25 to 200
micro g/mL. With increasing concentration of berry extract, increasing
inhibition of cell proliferation in all of the cell lines were observed, with
different degrees of potency between cell lines. The berry extracts were also
evaluated for their ability to stimulate apoptosis of the COX-2 expressing colon
cancer cell line, HT-29. Black raspberry and strawberry extracts showed the most
significant pro-apoptotic effects against this cell line. The data provided by
the current study and from other laboratories warrants further investigation
into the chemopreventive and chemotherapeutic effects of berries using in vivo
models.
PMID: 17147415 [PubMed - in process]
Absorption of anthocyanins from blueberry extracts by caco-2
human intestinal cell monolayers.
J Agric Food Chem. 2006 Jul 26;54(15):5651-8.
Department of Food Science and Technology, The University of
Georgia, Athens, Georgia 30602, USA.
Recent studies have shown that dietary polyphenols may
contribute to the prevention of cardiovascular disease and cancer. Anthocyanins
from different plant sources including blueberries have been shown to possess
potential anticancer activities. One of the key factors needed to correctly
relate the in vitro study results to human disease outcomes is information about
bioavailability. The objectives of the current study were to evaluate the
absorption of blueberry anthocyanin extracts using Caco-2 human intestinal cell
monolayers and investigate the effects of different aglycones, sugar moieties,
and chemical structure on bioavailability of different types of anthocyanins.
The results of this study showed that anthocyanins from blueberries could be
transported through the Caco-2 cell monolayers although the transport/absorption
efficiency was relatively low compared to other aglycone polyphenols. The
transport efficiency of anthocyanins averaged approximately 3-4% [less than 1%
in delphinidin glucoside (Dp-glc)]. No significant difference in
transport/absorption efficiency was observed among three blueberry cultivars.
The observed trends among different anthocyanins generally agreed well with some
published in vivo results. Dp-glc showed the lowest transport/absorption
efficiency, and malvidin glucoside (Mv-glc) showed the highest
transport/absorption efficiency. Our result indicates that more free hydroxyl
groups and less OCH(3) groups can decrease the bioavailability of anthocyanins.
In addition, cyanindin glucoside (Cy-glc) showed significantly higher transport
efficiency than cyanidin galactoside (Cy-gal), and peonidin glucoside (Pn-glc)
showed significantly higher transport efficiency than peonidin galactoside
(Pn-gal), indicating that glucose-based anthocyanins have higher bioavailability
than galactose-based anthocyanins.
PMID: 16848559 [PubMed - indexed for MEDLINE]
Differential effects of blueberry proanthocyanidins on
androgen sensitive and insensitive human prostate cancer cell lines.
Cancer Lett. 2006 Jan 18;231(2):240-6
Department of Natural Resources and Environmental Sciences,
University of Illinois at Urbana-Champaign, 1201 S. Dorner Dr, Urbana, IL 61801,
USA.
Blueberries are rich in health-promoting polyphenolic compounds
including proanthocyanidins. The purpose of this study was to determine if
proanthocyanidin-rich fractions from both wild and cultivated blueberry fruit
have the same inhibitory effects on the proliferation of LNCaP, an
androgen-sensitive prostate cancer cell line, and DU145, a more aggressive
androgen insensitive prostate cancer cell line. When 20 microg/ml of a wild
blueberry proanthocyanidin fraction (fraction 5) was added to LNCaP media,
growth was inhibited to 11% of control with an IC50 of 13.3 microg/ml. Two
similar proanthocyanidin-rich fractions from cultivated blueberries (fractions 4
and 5) at the same concentration inhibited LNCaP growth to 57 and 26% of control
with an IC50 of 22.7 and 5.8 microg/ml, respectively. In DU145 cells, the only
fraction that significantly reduced growth compared to control was fraction 4
from cultivated blueberries with an IC50 value of 74.4 microg/ml, indicating
only minor inhibitory activity. Differences in cell growth inhibition of LNCaP
and DU145 cell lines by blueberry fractions rich in proanthocyanidins indicate
that blueberry proanthocyanidins have an effect primarily on androgen-dependant
growth of prostate cancer cells. Possible molecular mechanisms for growth
inhibition are reviewed.
PMID: 16399225 [PubMed - indexed for MEDLINE]
Blueberry flavonoids inhibit matrix metalloproteinase
activity in DU145 human prostate cancer cells.
Biochem Cell Biol. 2005 Oct;83(5):637-43.
Department of Biology, University of Prince Edward Island, 550
UniversityAve., Charlottetown, PE C1A 4P3, Canada.
Regulation of the matrix metalloproteinases (MMPs), the major
mediators of extracellular matrix (ECM) degradation, is crucial to regulate ECM
proteolysis, which is important in metastasis. This study examined the effects
of 3 flavonoid-enriched fractions (a crude fraction, an anthocyanin-enriched
fraction, and a proanthocyanidin-enriched fraction), which were prepared from
lowbush blueberries (Vaccinium angustifolium), on MMP activity in DU145 human
prostate cancer cells in vitro. Using gelatin gel electrophoresis, MMP activity
was evaluated from cells after 24-hr exposure to blueberry fractions. All
fractions elicited an ability to decrease the activity of MMP-2 and MMP-9. Of
the fractions tested, the proanthocyanidin-enriched fraction was found to be the
most effective at inhibiting MMP activity in these cells. No induction of either
necrotic or apoptotic cell death was noted in these cells in response to
treatment with the blueberry fractions. These findings indicate that flavonoids
from blueberry possess the ability to effectively decrease MMP activity, which
may decrease overall ECM degradation. This ability may be important in
controlling tumor metastasis formation.
PMID: 16234852 [PubMed - indexed for MEDLINE]
Phenolic compounds from blueberries can inhibit colon cancer
cell proliferation and induce apoptosis.
J Agric Food Chem. 2005 Sep 7;53(18):7320-9
Department of Food Science and Technology, The University of
Georgia, Athens, Georgia 30602-7610, USA.
Research has shown that diets rich in phenolic compounds may be
associated with lower risks of several chronic diseases including cancer. This
study systematically evaluated the bioactivities of phenolic compounds in
rabbiteye blueberries and assessed their potential antiproliferation and
apoptosis induction effects using two colon cancer cell lines, HT-29 and Caco-2.
Polyphenols in three blueberry cultivars, Briteblue, Tifblue, and Powderblue,
were extracted and freeze-dried. The extracts were further separated into
phenolic acids, tannins, flavonols, and anthocyanins using an HLB cartridge and
LH20 column. Some individual phenolic acids and flavonoids were identified by
HPLC with >90% purity in anthocyanin fractions. The dried extracts and
fractions were added to the cell culture medium to test for antiproliferation
activities and induction of apoptosis. Flavonol and tannin fractions resulted in
50% inhibition of cell proliferation at concentrations of 70-100 and 50-100
microg/mL in HT-29 and Caco-2 cells, respectively. The phenolic acid fraction
showed relatively lower bioactivities with 50% inhibition at approximately 1000
microg/mL. The greatest antiproliferation effect among all four fractions was
from the anthocyanin fractions. Both HT-29 and Caco-2 cell growth was
significantly inhibited by >50% by the anthocyanin fractions at
concentrations of 15-50 microg/mL. Anthocyanin fractions also resulted in 2-7
times increases in DNA fragmentation, indicating the induction of apoptosis. The
effective dosage levels are close to the reported range of anthocyanin
concentrations in rat plasma. These findings suggest that blueberry intake may
reduce colon cancer risk.
Blueberryextract
|
|
Stroke and Blueberry
A study published in the May 2005 issue of the Journal of
Experimental Neurology tested the effects of blueberry to lessen the
consequences of stroke. Researchers fed three groups of rats chow that was
enriched with either blueberries, spirulina, spinach. A fourth group was fed
unenriched food. After four weeks an ischemic stroke with reperfusion was
introduced to the rats. In the blueberry fed rats the size of the area of the
brain damaged by the stroke was half that of the control group (Wang Y, Chang
CF, Chou J, Chen HL, Deng X, Harvey BK, Cadet JL, Bickford PC. Dietary
supplementation with blueberries, spinach, or spirulina reduces ischemic brain
damage. Exp Neurol. 2005 May;193(1):75-84).
Clinical Abstracts
Dietary supplementation with blueberries, spinach, or
spirulina reduces ischemic brain damage.
Exp Neurol. 2005 May;193(1):75-84
National Institute on Drug Abuse, Intramural Research Program,
Baltimore, MD 21224, USA.
Free radicals are involved in neurodegenerative disorders, such
as ischemia and aging. We have previously demonstrated that treatment with diets
enriched with blueberry, spinach, or spirulina have been shown to reduce
neurodegenerative changes in aged animals. The purpose of this study was to
determine if these diets have neuroprotective effects in focal ischemic brain.
Adult male Sprague-Dawley rats were fed with equal amounts of diets (blueberry,
spinach, and spirulina) or with control diet. After 4 weeks of feeding, all
animals were anesthetized with chloral hydrate. The right middle cerebral artery
was ligated with a 10-O suture for 60 min. The ligature was later removed to
allow reperfusional injury. Animals were sacrificed and brains were removed for
caspase-3 enzymatic assays and triphenyltetrazolium chloride staining at 8 and
48 h after the onset of reperfusion. A subgroup of animals was used for
locomotor behavior and biochemical assays. We found that animals which received
blueberry, spinach, or spirulina enriched diets had a significant reduction in
the volume of infarction in the cerebral cortex and an increase in post-stroke
locomotor activity. There was no difference in blood biochemistry, blood CO2,
and electrolyte levels among all groups, suggesting that the protection was not
indirectly mediated through the changes in physiological functions. Animals
treated with blueberry, spinach, or spirulina had significantly lower caspase-3
activity in the ischemic hemisphere. In conclusion, our data suggest that
chronic treatment with blueberry, spinach, or spirulina reduces
ischemia/reperfusion-induced apoptosis and cerebral infarction.
PMID: 15817266 [PubMed - indexed for MEDLINE]
Blueberry- and spirulina-enriched diets enhance striatal
dopamine recovery and induce a rapid, transient microglia activation after
injury of the rat nigrostriatal dopamine system.
Exp Neurol. 2005 Dec;196(2):298-307. Epub 2005 Sep 19
Department of Integrative Medical Biology, Umea University, S
901 87 Umea, Sweden. ingrid.stromberg@histocel.umu.se
Neuroinflammation plays a critical role in loss of dopamine
neurons during brain injury and in neurodegenerative diseases. Diets enriched in
foods with antioxidant and anti-inflammatory actions may modulate this
neuroinflammation. The model of 6-hydroxydopamine (6-OHDA) injected into the
dorsal striatum of normal rats, causes a progressive loss of dopamine neurons in
the ventral mesencephalon. In this study, we have investigated the inflammatory
response following 6-OHDA injected into the striatum of adult rats treated with
diet enriched in blueberry or spirulina. One week after the dopamine lesion, a
similar size of dopamine degeneration was found in the striatum and in the
globus pallidus in all lesioned animals. At 1 week, a significant increase in
OX-6- (MHC class II) positive microglia was found in animals fed with blueberry-
and spirulina-enriched diets in both the striatum and the globus pallidus. These
OX-6-positive cells were located within the area of tyrosine hydroxylase (TH)
-negativity. At 1 month after the lesion, the number of OX-6-positive cells was
reduced in diet-treated animals while a significant increase beyond that
observed at 1 week was now present in lesioned control animals. Dopamine
recovery as revealed by TH-immunohistochemistry was significantly enhanced at 4
weeks postlesion in the striatum while in the globus pallidus the density of
TH-positive nerve fibers was not different from control-fed lesioned animals. In
conclusion, enhanced striatal dopamine recovery appeared in animals treated with
diet enriched in antioxidants and anti-inflammatory phytochemicals and coincided
with an early, transient increase in OX-6-positive microglia.
PMID: 16176814 [PubMed - indexed for MEDLINE] |
PMID: 16131149 [PubMed - indexed for MEDLINE |